Beacon Therapeutics Beacon Therapeutics

Study Locations

Find a participating clinical site near you. All sites accept referrals and welcome questions from prospective participants.

5 of 5 sites

Memorial Sloan Kettering Cancer Center

Enrolling
1275 York AvenueNew York, NY, 10065United States
Principal investigator Dr. Jane Okafor, MD
Phone +1-212-639-2000
Hours Mon-Fri 8:00-17:00
EnglishSpanishMandarin

Accepting patients with stage III/IV NSCLC who have completed at least one prior line of therapy.

Dana-Farber Cancer Institute

Enrolling
450 Brookline AvenueBoston, MA, 02215United States
Principal investigator Dr. Marcus Chen, MD, PhD
Phone +1-617-632-3000
Hours Mon-Fri 7:30-18:00
EnglishPortuguese

The Royal Marsden NHS Foundation Trust

Enrollment paused
203 Fulham RoadLondon, SW3 6JJUnited Kingdom
Principal investigator Dr. Priya Ramanathan, FRCP
Phone +44-20-7352-8171
Hours Mon-Fri 9:00-17:00
English

Enrollment temporarily paused pending protocol amendment. Screening will resume Q2.

Charité – Universitätsmedizin Berlin

Enrolling
Charitéplatz 1Berlin, 10117Germany
Principal investigator Prof. Dr. Lukas Weber
Phone +49-30-450-50
Hours Mon-Fri 8:00-16:30
GermanEnglish

Peter MacCallum Cancer Centre

Enrollment closed
305 Grattan StreetMelbourne, VIC, 3000Australia
Principal investigator Dr. Eleanor Whitcomb
Phone +61-3-8559-5000
English

Enrollment closed. Follow-up visits continue for participants already enrolled.